Young Adult With Acute Lymphoblastic Leukemia (ALL) : a Multicentric Protocol. GRAALL [Group for Research on Adult Acute Lymphoblastic Leukemia] 2005 : T ALL or B ALL Non Ph GRAALL 2005 R : B ALL Non Ph CD20+ GRAAPH 2005 : ALL Ph

Trial Profile

Young Adult With Acute Lymphoblastic Leukemia (ALL) : a Multicentric Protocol. GRAALL [Group for Research on Adult Acute Lymphoblastic Leukemia] 2005 : T ALL or B ALL Non Ph GRAALL 2005 R : B ALL Non Ph CD20+ GRAAPH 2005 : ALL Ph

Completed
Phase of Trial: Phase III

Latest Information Update: 06 Dec 2016

At a glance

  • Drugs Rituximab (Primary) ; Antineoplastics; Cyclophosphamide; Imatinib
  • Indications Acute lymphoblastic leukaemia
  • Focus Therapeutic Use
  • Most Recent Events

    • 06 Dec 2016 Results of the prophylactic replacement strategy (n=787) presented at the 58th Annual Meeting and Exposition of the American Society of Hematology
    • 06 Dec 2016 Results of a retrospective analysis (n=787) assessing the occurrence of Bacterial infections during induction treatment, presented at the 58th Annual Meeting and Exposition of the American Society of Hematology
    • 06 Dec 2016 Results assessing upper age limit for a pediatric-like strategy in younger adults with Acute Lymphoblastic Leukemia (Graall-2005) presented at the 58th Annual Meeting and Exposition of the American Society of Hematology
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top